BioXcel Therapeutics(BTAI) - 2023 Q4 - Earnings Call Transcript

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Conference Call March 12, 2024 8:00 AM ET Company Participants Vimal Mehta - Chief Executive Officer Vince O'Neill - Chief of Product and Development Medical Officer Richard Steinhart - Chief Financial Officer Robert Risinger - Chief Medical Officer, Neuroscience Matt Wiley - Chief Commercial Officer Conference Call Participants Greg Harrison - Bank of America Robyn Karnauskas - Truist Securities Graig Suvannavejh - Mizuho Securities Sumant Kulkarni ...